Inception Return
(1/26/2017)
|
15.68 %
|
YTD Return
|
34.29 %
|
|
NAVPS
(12/6/2024)
|
$32.88
|
Change
|
$0.45 / 1.38 %
|
|
Growth of $10,000
(As of October 31, 2024)
|
MER
|
2.49 %
|
Assets ($mil)
|
-
|
Rank (1Yr)
|
127/1279
|
Std Dev (3Yr)
|
15.32 %
|
Volatility Ranking (3Yr)
|
8/10
|
RRSP Eligibility
|
Yes
|
Load
|
Front Fee Only
|
Max Front End
|
-
|
Max Back End
|
6.00 %
|
Sales Status
|
Open
|
|
Objective
The Fund aims to achieve long-term capital appreciation. It seeks a similar return to its underlying fund, which is also managed by Fidelity, by investing substantially all of its assets in units of that fund. The underlying fund aims to achieve long-term capital appreciation by investing primarily in equity securities of companies anywhere in the world, with an emphasis on U.S. securities, whose value is believed to be not fully recognized by the public.
|
Fund Manager
Fidelity Investments Canada ULC
Portfolio Manager
William Danoff , Fidelity Investments Canada ULC
Sub-Advisor
Fidelity Management & Research Company LLC
|
Asset Allocation
(As of September 30, 2024)
|
Sector Allocation
(As of September 30, 2024)
|
Geographic Allocation
(As of September 30, 2024)
|
Top 10 Holdings
Name | Asset | Sector | Geographic | Percent |
Meta Platforms Inc Cl A | US Equity | Technology | United States | 0.00% |
NVIDIA Corp | US Equity | Technology | United States | 0.00% |
Berkshire Hathaway Inc Cl A | US Equity | Financial Services | United States | 0.00% |
Microsoft Corp | US Equity | Technology | United States | 0.00% |
Amazon.com Inc | US Equity | Consumer Services | United States | 0.00% |
Apple Inc | US Equity | Technology | United States | 0.00% |
Eli Lilly and Co | US Equity | Healthcare | United States | 0.00% |
Alphabet Inc Cl A | US Equity | Technology | United States | 0.00% |
Vertex Pharmaceuticals Inc | US Equity | Healthcare | United States | 0.00% |
Fidelity U.S. Money Market Investment Trust O | Cash and Equivalents | Cash and Cash Equivalent | United States | 0.00% |
Performance Data
(As of October 31, 2024)
|
Return (%)
|
Annualized Return (%)
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
Fund
|
2.51
|
5.55
|
15.81
|
34.29
|
44.02
|
11.38
|
16.59
|
-
|
Benchmark
|
2.12
|
4.47
|
15.49
|
27.28
|
38.46
|
13.41
|
16.57
|
15.41
|
Quartile Ranking
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
-
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
Fund
|
28.49
|
-22.37
|
20.08
|
27.62
|
20.70
|
3.93
|
-
|
-
|
-
|
-
|
Benchmark
|
23.32
|
-12.52
|
28.16
|
16.07
|
25.18
|
3.98
|
13.80
|
8.65
|
20.77
|
24.19
|
Quartile Ranking
|
1
|
4
|
4
|
1
|
4
|
1
|
-
|
-
|
-
|
-
|